{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,23]],"date-time":"2026-09-23T02:58:32Z","timestamp":1790132312659,"version":"4.0.1"},"reference-count":43,"publisher":"Springer Science and Business Media LLC","issue":"7","license":[{"start":{"date-parts":[[2020,1,14]],"date-time":"2020-01-14T00:00:00Z","timestamp":1578960000000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"},{"start":{"date-parts":[[2020,1,14]],"date-time":"2020-01-14T00:00:00Z","timestamp":1578960000000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"funder":[{"name":"Ministry of Health of the Italian Government","award":["Progetto Ordinario Ricerca Finalizzata RF-2013-02356201"],"award-info":[{"award-number":["Progetto Ordinario Ricerca Finalizzata RF-2013-02356201"]}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["J Endocrinol Invest"],"published-print":{"date-parts":[[2020,7]]},"DOI":"10.1007\/s40618-019-01178-4","type":"journal-article","created":{"date-parts":[[2020,1,14]],"date-time":"2020-01-14T17:03:06Z","timestamp":1579021386000},"page":"947-958","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":23,"title":["MicroRNAs expression in pituitary tumors: differences related to functional status, pathological features, and clinical behavior"],"prefix":"10.1007","volume":"43","author":[{"given":"T. M.","family":"Vicchio","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"F.","family":"Aliqu\u00f2","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"R. M.","family":"Ruggeri","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"M.","family":"Ragonese","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"G.","family":"Giuffrida","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"O. R.","family":"Cotta","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"F.","family":"Spagnolo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"M. L.","family":"Torre","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"A.","family":"Alibrandi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"A.","family":"Asmundo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"F. F.","family":"Angileri","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"F.","family":"Esposito","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"F.","family":"Polito","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"R.","family":"Oteri","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"M. H.","family":"Aguennouz","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"S.","family":"Cannav\u00f2","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-7472-6598","authenticated-orcid":false,"given":"F.","family":"Ferra\u00f9","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2020,1,14]]},"reference":[{"key":"1178_CR1","doi-asserted-by":"publisher","first-page":"195","DOI":"10.1159\/000110624","volume":"68","author":"AF Daly","year":"2007","unstructured":"Daly AF, Burlacu MC, Livadariu E, Beckers A (2007) The epidemiology and management of pituitary incidentalomas. Horm Res 68:195\u2013198. https:\/\/doi.org\/10.1159\/000110624","journal-title":"Horm Res"},{"key":"1178_CR2","doi-asserted-by":"publisher","first-page":"336","DOI":"10.3171\/2010.8.JNS10290","volume":"114","author":"G Zada","year":"2011","unstructured":"Zada G, Woodmansee WW, Ramkissoon S, Amadio J, Nose V, Laws ER Jr (2011) Atypical pituitary adenomas: incidence, clinical characteristics, and implications. J Neurosurg 114:336\u2013344. https:\/\/doi.org\/10.3171\/2010.8.JNS10290","journal-title":"J Neurosurg"},{"key":"1178_CR3","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1530\/EJE-17-0796","volume":"178","author":"G Raverot","year":"2018","unstructured":"Raverot G, Burman P, McCormack A et al (2018) European Society of Endocrinology Clinical Practice Guidelines for the management of aggressive pituitary tumours and carcinomas. Eur J Endcrinol 178:1\u201324. https:\/\/doi.org\/10.1530\/EJE-17-0796","journal-title":"Eur J Endcrinol"},{"key":"1178_CR4","doi-asserted-by":"publisher","first-page":"105","DOI":"10.1007\/s10143-016-0740-9","volume":"40","author":"DBD Caro","year":"2016","unstructured":"Caro DBD, Solari D, Pagliuca F et al (2016) Atypical pituitary adenomas: clinical characteristics and role of Ki-67 and p53 in prognostic and therapeutic evaluation. A series of 50 patients. Neurosurg Rev 40:105\u2013114. https:\/\/doi.org\/10.1007\/s10143-016-0740-9","journal-title":"Neurosurg Rev"},{"key":"1178_CR5","doi-asserted-by":"publisher","first-page":"50","DOI":"10.1186\/s40478-015-0229-8","volume":"3","author":"CP Miermeister","year":"2015","unstructured":"Miermeister CP, Petersenn S, Buchfelder M et al (2015) Histological criteria for atypical pituitary adenomas\u2014data from the German pituitary adenoma registry suggests modifications. Acta Neuropathol Commun 3:50. https:\/\/doi.org\/10.1186\/s40478-015-0229-8","journal-title":"Acta Neuropathol Commun"},{"key":"1178_CR6","doi-asserted-by":"publisher","first-page":"115","DOI":"10.1007\/s12022-016-9419-6","volume":"27","author":"W Saeger","year":"2016","unstructured":"Saeger W, Petersenn S, Sch\u00f6fl C et al (2016) Emerging histopathological and genetic parameters of pituitary adenomas: clinical impact and recommendation for future WHO classification. Endocr Pathol 27:115\u2013122. https:\/\/doi.org\/10.1007\/s12022-016-9419-6","journal-title":"Endocr Pathol"},{"key":"1178_CR7","doi-asserted-by":"publisher","first-page":"324","DOI":"10.1097\/MED.0000000000000266","volume":"23","author":"AM Robertson","year":"2016","unstructured":"Robertson AM, Heaney AP (2016) Molecular markers in pituitary tumors. Curr Opin Endocrinol Diabetes Obes 23:324\u2013330. https:\/\/doi.org\/10.1097\/MED.0000000000000266","journal-title":"Curr Opin Endocrinol Diabetes Obes"},{"key":"1178_CR8","doi-asserted-by":"publisher","first-page":"350","DOI":"10.1038\/nature02871","volume":"431","author":"V Ambros","year":"2004","unstructured":"Ambros V (2004) The functions of animal microRNAs. Nature 431:350\u2013355. https:\/\/doi.org\/10.1038\/nature02871","journal-title":"Nature"},{"key":"1178_CR9","doi-asserted-by":"publisher","first-page":"592","DOI":"10.1016\/j.bbadis.2011.02.002","volume":"1812","author":"MJ Bueno","year":"2011","unstructured":"Bueno MJ, Malumbres M (2011) MicroRNAs and the cell cycle. Biochim Biophys Acta 1812:592\u2013601. https:\/\/doi.org\/10.1016\/j.bbadis.2011.02.002","journal-title":"Biochim Biophys Acta"},{"key":"1178_CR10","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1016\/j.ydbio.2006.08.028","volume":"302","author":"B Zhang","year":"2007","unstructured":"Zhang B, Pan X, Cobb GP, Anderson TA (2007) MicroRNAs as oncogenes and tumor suppressors. Dev Biol 302:1\u201312. https:\/\/doi.org\/10.1016\/j.ydbio.2006.08.028","journal-title":"Dev Biol"},{"key":"1178_CR11","doi-asserted-by":"publisher","first-page":"15004","DOI":"10.1038\/sigtrans.2015.4","volume":"1","author":"Y Peng","year":"2016","unstructured":"Peng Y, Croce CM (2016) The role of MicroRNAs in human cancer. Signal Transduct Target Ther 1:15004. https:\/\/doi.org\/10.1038\/sigtrans.2015.4","journal-title":"Signal Transduct Target Ther"},{"key":"1178_CR12","doi-asserted-by":"publisher","first-page":"2735","DOI":"10.3892\/ol.2017.7638","volume":"15","author":"W Tan","year":"2018","unstructured":"Tan W, Liu B, Qu S, Liang G, Luo W, Gong C (2018) MicroRNAs and cancer: key paradigms in molecular therapy. Oncol Lett 15:2735\u20132742. https:\/\/doi.org\/10.3892\/ol.2017.7638","journal-title":"Oncol Lett"},{"key":"1178_CR13","doi-asserted-by":"publisher","first-page":"179","DOI":"10.1055\/s-0043-123763","volume":"50","author":"Y Feng","year":"2018","unstructured":"Feng Y, Mao ZG, Wang X et al (2018) MicroRNAs and target genes in pituitary adenomas. Horm Metab Res 50:179\u2013192. https:\/\/doi.org\/10.1055\/s-0043-123763","journal-title":"Horm Metab Res"},{"key":"1178_CR14","doi-asserted-by":"publisher","first-page":"473","DOI":"10.3275\/7905","volume":"35","author":"RM Ruggeri","year":"2012","unstructured":"Ruggeri RM, Costa G, Simone A et al (2012) Cell proliferation parameters and apoptosis indices in pituitary macroadenomas. J Endocrinol Invest 35:473\u2013478. https:\/\/doi.org\/10.3275\/7905","journal-title":"J Endocrinol Invest"},{"key":"1178_CR15","doi-asserted-by":"publisher","first-page":"1063","DOI":"10.1038\/nmeth.2697","volume":"10","author":"SA Bustin","year":"2013","unstructured":"Bustin SA, Benes V, Garson J (2013) The need for transparency and good practices in the qPCR literature. Nat Methods 10:1063\u20131067. https:\/\/doi.org\/10.1038\/nmeth.2697","journal-title":"Nat Methods"},{"key":"1178_CR16","doi-asserted-by":"publisher","first-page":"e45","DOI":"10.1093\/nar\/29.9.e45","volume":"29","author":"MW Pfaffl","year":"2001","unstructured":"Pfaffl MW (2001) A new mathematical model for relative quantification in real-time RT-PCR. Nucleic Acids Res 29:e45. https:\/\/doi.org\/10.1093\/nar\/29.9.e45","journal-title":"Nucleic Acids Res"},{"key":"1178_CR17","doi-asserted-by":"publisher","first-page":"1259","DOI":"10.1007\/s00277-018-3296-7","volume":"97","author":"C Musolino","year":"2018","unstructured":"Musolino C, Oteri G, Allegra A et al (2018) Altered microRNA expression profile in the peripheral lymphoid compartment of multiple myeloma patients with bisphosphonate-induced osteonecrosis of the jaw. Ann Hematol 97:1259\u20131269. https:\/\/doi.org\/10.1007\/s00277-018-3296-7","journal-title":"Ann Hematol"},{"key":"1178_CR18","doi-asserted-by":"publisher","first-page":"66","DOI":"10.1186\/1479-5876-12-66","volume":"12","author":"W Zhang","year":"2014","unstructured":"Zhang W, Zang J, Jing X et al (2014) Identification of candidate miRNA biomarkers from miRNA regulatory network with application to prostate cancer. J Transl Med 12:66. https:\/\/doi.org\/10.1186\/1479-5876-12-66","journal-title":"J Transl Med"},{"key":"1178_CR19","doi-asserted-by":"publisher","first-page":"2449","DOI":"10.3892\/or.2017.5502","volume":"37","author":"Y Zhao","year":"2017","unstructured":"Zhao Y, Yan M, Yun Y et al (2017) MicroRNA-455-3p functions as a tumor suppressor by targeting eIF4E in prostate cancer. Oncol Rep 37:2449\u20132458. https:\/\/doi.org\/10.3892\/or.2017.5502","journal-title":"Oncol Rep"},{"key":"1178_CR20","doi-asserted-by":"publisher","first-page":"370","DOI":"10.1002\/jcp.20832","volume":"210","author":"A Bottoni","year":"2007","unstructured":"Bottoni A, Ferracin M, Tagliati F et al (2007) Identification of differentially expressed microRNAs by microarray: a possible role for microRNA genes in pituitary adenomas. J Cell Physiol 210:370\u2013377. https:\/\/doi.org\/10.1002\/jcp.20832","journal-title":"J Cell Physiol"},{"key":"1178_CR21","doi-asserted-by":"publisher","first-page":"E1128","DOI":"10.1210\/jc.2011-3482","volume":"97","author":"D D\u2019Angelo","year":"2012","unstructured":"D\u2019Angelo D, Palmieri D, Mussnich P et al (2012) Altered microRNA expression profile in human pituitary GH adenomas: down-regulation of miRNA targeting HMGA1, HMGA2, and E2F1. J Clin Endocrinol Metab 97:E1128\u2013E1138. https:\/\/doi.org\/10.1210\/jc.2011-3482","journal-title":"J Clin Endocrinol Metab"},{"key":"1178_CR22","doi-asserted-by":"publisher","first-page":"889","DOI":"10.1007\/BF03346759","volume":"36","author":"MR Gadelha","year":"2013","unstructured":"Gadelha MR, Kasuki L, D\u00e8nes J, Trivellin G, Korbonits M (2013) MicroRNAs: suggested role in pituitary adenoma pathogenesis. J. Endocrinol. Invest 36:889\u2013895. https:\/\/doi.org\/10.1007\/BF03346759","journal-title":"J. Endocrinol. Invest"},{"key":"1178_CR23","doi-asserted-by":"publisher","first-page":"79","DOI":"10.1186\/1746-1596-5-79","volume":"5","author":"ZG Mao","year":"2010","unstructured":"Mao ZG, He DS, Zhou J et al (2010) Differential expression of microRNAs in GH-secreting pituitary adenomas. Diagn Pathol 5:79. https:\/\/doi.org\/10.1186\/1746-1596-5-79","journal-title":"Diagn Pathol"},{"key":"1178_CR24","doi-asserted-by":"publisher","first-page":"E708","DOI":"10.1152\/ajpendo.00546.2011","volume":"303","author":"G Trivellin","year":"2012","unstructured":"Trivellin G, Butz H, Delhove J et al (2012) MicroRNA miR-107 is overexpressed in pituitary adenomas and inhibits the expression of aryl hydrocarbon receptor-interacting protein in vitro. Am J Physiol Endocrinol Metab 303:E708\u2013E719. https:\/\/doi.org\/10.1152\/ajpendo.00546.2011","journal-title":"Am J Physiol Endocrinol Metab"},{"key":"1178_CR25","doi-asserted-by":"publisher","first-page":"2","DOI":"10.2174\/2211536605666161208154633","volume":"6","author":"M Williams","year":"2017","unstructured":"Williams M, Cheng YY, Blenkiron C, Reid G (2017) Exploring mechanisms of MicroRNA downregulation in cancer. MicroRNA 6:2\u201316. https:\/\/doi.org\/10.2174\/2211536605666161208154633","journal-title":"MicroRNA"},{"key":"1178_CR26","doi-asserted-by":"publisher","first-page":"188","DOI":"10.3389\/fendo.2015.00188","volume":"6","author":"HL Robbins","year":"2016","unstructured":"Robbins HL, Hague A (2016) The PI3K\/Akt pathway in tumors of endocrine tissues. Front Endocrinol (Lausanne) 6:188. https:\/\/doi.org\/10.3389\/fendo.2015.00188","journal-title":"Front Endocrinol (Lausanne)"},{"key":"1178_CR27","doi-asserted-by":"publisher","first-page":"735","DOI":"10.1007\/s12020-013-9950-x","volume":"44","author":"M Trovato","year":"2013","unstructured":"Trovato M, Torre ML, Ragonese M et al (2013) HGF\/c-met system targeting PI3K\/AKT and STAT3\/phosphorylated-STAT3 pathways in pituitary adenomas: an immunohistochemical characterization in view of targeted therapies. Endocrine 44:735\u2013743. https:\/\/doi.org\/10.1007\/s12020-013-9950-x","journal-title":"Endocrine"},{"key":"1178_CR28","doi-asserted-by":"publisher","first-page":"81","DOI":"10.1016\/j.mce.2016.12.019","volume":"457","author":"S Cannavo","year":"2017","unstructured":"Cannavo S, Trimarchi F, Ferra\u00f9 F (2017) Acromegaly, genetic variants of the aryl hydrocarbon receptor pathway and environmental burden. Mol Cell Endocrinol 457:81\u201388. https:\/\/doi.org\/10.1016\/j.mce.2016.12.019","journal-title":"Mol Cell Endocrinol"},{"key":"1178_CR29","doi-asserted-by":"publisher","first-page":"1872","DOI":"10.1210\/jc.2015-4191","volume":"101","author":"S Cannavo","year":"2016","unstructured":"Cannavo S, Ragonese M, Puglisi S et al (2016) Acromegaly is more severe in patients with AHR or AIP gene variants living in highly polluted areas. J Clin Endocrinol Metab 101:1872\u20131879. https:\/\/doi.org\/10.1210\/jc.2015-4191","journal-title":"J Clin Endocrinol Metab"},{"key":"1178_CR30","doi-asserted-by":"publisher","first-page":"825","DOI":"10.1007\/s40618-018-0988-8","volume":"42","author":"F Ferra\u00f9","year":"2019","unstructured":"Ferra\u00f9 F, Romeo PD, Puglisi S et al (2019) GSTP1 gene methylation and AHR rs2066853 variant predict resistance to first generation somatostatin analogs in patients with acromegaly. J Endocrinol Invest 42:825\u2013831. https:\/\/doi.org\/10.1007\/s40618-018-0988-8","journal-title":"J Endocrinol Invest"},{"key":"1178_CR31","doi-asserted-by":"publisher","first-page":"249","DOI":"10.1111\/cen.12424","volume":"81","author":"S Cannavo","year":"2014","unstructured":"Cannavo S, Ferrau F, Ragonese M et al (2014) Increased frequency of the rs2066853 variant of aryl hydrocarbon receptor gene in patients with acromegaly. Clin Endocrinol (Oxf) 81:249\u2013253. https:\/\/doi.org\/10.1111\/cen.12424","journal-title":"Clin Endocrinol (Oxf)"},{"key":"1178_CR32","doi-asserted-by":"publisher","first-page":"71","DOI":"10.1186\/1479-5876-12-71","volume":"12","author":"L Zhenye","year":"2014","unstructured":"Zhenye L, Chuzhong L, Youtu W (2014) The expression of TGF-\u03b21, Smad3, phospho-Smad3 and Smad7 is correlated with the development and invasion of nonfunctioning pituitary adenomas. J Transl Med 12:71. https:\/\/doi.org\/10.1186\/1479-5876-12-71","journal-title":"J Transl Med"},{"key":"1178_CR33","doi-asserted-by":"publisher","first-page":"70","DOI":"10.1186\/s12929-016-0287-7","volume":"23","author":"HT Tzeng","year":"2016","unstructured":"Tzeng HT, Wang YC (2016) Rab-mediated vesicle trafficking in cancer. J Biomed Sci 23:70. https:\/\/doi.org\/10.1186\/s12929-016-0287-7","journal-title":"J Biomed Sci"},{"key":"1178_CR34","doi-asserted-by":"publisher","first-page":"2269","DOI":"10.1210\/jc.2007-1893","volume":"93","author":"R Vazquez-Martinez","year":"2008","unstructured":"Vazquez-Martinez R, Martinez-Fuentes AJ, Pulido MR et al (2008) Rab18 is reduced in pituitary tumors causing acromegaly and its overexpression reverts growth hormone hypersecretion. J Clin Endocrinol Metab 93:2269\u20132276. https:\/\/doi.org\/10.1210\/jc.2007-1893","journal-title":"J Clin Endocrinol Metab"},{"key":"1178_CR35","doi-asserted-by":"publisher","first-page":"709","DOI":"10.1507\/endocrj.EJ18-0487","volume":"66","author":"Z He","year":"2019","unstructured":"He Z, Chen L, Hu X, Tang J et al (2019) Next-generation sequencing of microRNAs reveals a unique expression pattern in different types of pituitary adenomas. Endocr J 66:709\u2013722. https:\/\/doi.org\/10.1507\/endocrj.EJ18-0487","journal-title":"Endocr J"},{"key":"1178_CR36","doi-asserted-by":"publisher","first-page":"891","DOI":"10.1038\/bjc.2015.19","volume":"112","author":"I Fukumoto","year":"2015","unstructured":"Fukumoto I, Hanazawa T, Kinoshita T et al (2015) MicroRNA expression signature of oral squamous cell carcinoma: functional role of microRNA-26a\/b in the modulation of novel cancer pathways. Br J Cancer 112:891\u2013900. https:\/\/doi.org\/10.1038\/bjc.2015.19","journal-title":"Br J Cancer"},{"key":"1178_CR37","doi-asserted-by":"publisher","first-page":"354","DOI":"10.1038\/bjc.2015.19","volume":"115","author":"K Miyamoto","year":"2016","unstructured":"Miyamoto K, Seki N, Matsushita R, Yonemori M et al (2016) Tumour-suppressive miRNA-26a-5p and miR-26b-5p inhibit cell aggressiveness by regulating PLOD2 in bladder cancer. Br J Cancer 115:354\u2013363. https:\/\/doi.org\/10.1038\/bjc.2015.19","journal-title":"Br J Cancer"},{"key":"1178_CR38","doi-asserted-by":"publisher","first-page":"e2892","DOI":"10.1038\/cddis.2017.281","volume":"8","author":"Y Li","year":"2017","unstructured":"Li Y, Sun Z, Liu B, Shan Y, Zhao L, Jia L (2017) Tumor-suppressive miR-26a and miR-26b inhibit cell aggressiveness by regulating FUT4 in colorectal cancer. Cell Death Dis 8:e2892. https:\/\/doi.org\/10.1038\/cddis.2017.281","journal-title":"Cell Death Dis"},{"key":"1178_CR39","first-page":"76","volume":"21","author":"YH Liu","year":"2017","unstructured":"Liu YH, Li B, Meng FG, Qiu L (2017) MiR-508-5p is a prognostic marker and inhibits cell proliferation and migration in glioma. Eur Rev Med Pharmacol Sci 21:76\u201381","journal-title":"Eur Rev Med Pharmacol Sci"},{"key":"1178_CR40","doi-asserted-by":"publisher","first-page":"160275","DOI":"10.1098\/rsob.160275","volume":"6","author":"CK Chan","year":"2016","unstructured":"Chan CK, Pan Y, Nyberg K et al (2016) Tumour-suppressor microRNAs regulate ovarian cancer cell physical properties and invasive behaviour. Open Biol 6:160275. https:\/\/doi.org\/10.1098\/rsob.160275","journal-title":"Open Biol"},{"key":"1178_CR41","unstructured":"Jia Z, Wang K, Wang G, Zhang A, Pu P (2013) MiR-30a-5p antisense oligonucleotide suppresses glioma cell growth by targeting PLoS ONE 8: e55008. 10.1371\/journal.pone.0055008."},{"key":"1178_CR42","doi-asserted-by":"publisher","first-page":"2077","DOI":"10.1002\/ijc.26232","volume":"130","author":"Y Ma","year":"2012","unstructured":"Ma Y, Zhang P, Yang J, Liu Z, Yang Z, Qin H (2012) Candidate microRNA biomarkers in human colorectal cancer: systematic review profiling studies and experimental validation. Int J Cancer 130:2077\u20132087. https:\/\/doi.org\/10.1002\/ijc.26232","journal-title":"Int J Cancer"},{"key":"1178_CR43","doi-asserted-by":"crossref","unstructured":"Ruan P, Tao Z, Tan A (2018) Low expression of miR-30a-5p induced the proliferation and invasion of oral cancer via promoting the expression of FAP. Biosci Rep 38(1). 10.1042\/BSR20171027.","DOI":"10.1042\/BSR20171027"}],"container-title":["Journal of Endocrinological Investigation"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s40618-019-01178-4.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s40618-019-01178-4\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s40618-019-01178-4.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2021,1,13]],"date-time":"2021-01-13T21:59:36Z","timestamp":1610575176000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s40618-019-01178-4"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020,1,14]]},"references-count":43,"journal-issue":{"issue":"7","published-print":{"date-parts":[[2020,7]]}},"alternative-id":["1178"],"URL":"https:\/\/doi.org\/10.1007\/s40618-019-01178-4","relation":{},"ISSN":["1720-8386"],"issn-type":[{"value":"1720-8386","type":"electronic"}],"subject":[],"published":{"date-parts":[[2020,1,14]]},"assertion":[{"value":"3 July 2019","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"31 December 2019","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"14 January 2020","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Compliance with ethical standards"}},{"value":"All procedures performed in the study were in accordance with the ethical standards of the institutional and\/or national research committee and with the 1964 Helsinki declaration and its later amendments or comparable ethical standards.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethical approval"}},{"value":"Informed consent was obtained from all individual participants included in the study.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Informed consent"}}]}}